Tower Research Capital (TRC)’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$33.3K Buy
4,833
+2,002
+71% +$13.8K ﹤0.01% 3324
2025
Q1
$15K Sell
2,831
-1,895
-40% -$10.1K ﹤0.01% 3247
2024
Q4
$55.8K Sell
4,726
-8,126
-63% -$95.9K ﹤0.01% 2483
2024
Q3
$265K Buy
12,852
+12,166
+1,773% +$251K 0.01% 1360
2024
Q2
$31K Sell
686
-1,040
-60% -$47.1K ﹤0.01% 3464
2024
Q1
$67.7K Buy
1,726
+536
+45% +$21K ﹤0.01% 2077
2023
Q4
$7.19K Buy
+1,190
New +$7.19K ﹤0.01% 4646
2023
Q3
Sell
-147
Closed -$1.15K 5980
2023
Q2
$1.15K Sell
147
-388
-73% -$3.04K ﹤0.01% 5427
2023
Q1
$4K Sell
535
-1,350
-72% -$10.1K ﹤0.01% 5057
2022
Q4
$6K Buy
1,885
+1,638
+663% +$5.21K ﹤0.01% 4697
2022
Q3
$1K Buy
+247
New +$1K ﹤0.01% 5744
2022
Q2
Sell
-303
Closed -$5K 6122
2022
Q1
$5K Buy
303
+217
+252% +$3.58K ﹤0.01% 5034
2021
Q4
$2K Buy
86
+83
+2,767% +$1.93K ﹤0.01% 5608
2021
Q3
$0 Sell
3
-563
-99% ﹤0.01% 5809
2021
Q2
$31K Sell
566
-1,770
-76% -$96.9K ﹤0.01% 3446
2021
Q1
$138K Buy
2,336
+1,316
+129% +$77.7K ﹤0.01% 2322
2020
Q4
$38K Sell
1,020
-2,941
-74% -$110K ﹤0.01% 3368
2020
Q3
$214K Buy
3,961
+3,148
+387% +$170K ﹤0.01% 2516
2020
Q2
$205K Buy
+813
New +$205K 0.01% 1762
2020
Q1
Sell
-13
Closed -$2K 3157
2019
Q4
$2K Sell
13
-121
-90% -$18.6K ﹤0.01% 3028
2019
Q3
$20K Buy
134
+131
+4,367% +$19.6K ﹤0.01% 2469
2019
Q2
$1K Buy
+3
New +$1K ﹤0.01% 3412
2018
Q3
Sell
-162
Closed -$25K 3823
2018
Q2
$25K Buy
+162
New +$25K ﹤0.01% 2293
2018
Q1
Sell
-39
Closed -$8K 3346
2017
Q4
$8K Sell
39
-33
-46% -$6.77K ﹤0.01% 2660
2017
Q3
$16K Buy
72
+45
+167% +$10K ﹤0.01% 2848
2017
Q2
$5K Buy
+27
New +$5K ﹤0.01% 1970
2017
Q1
Sell
-17
Closed -$4K 3168
2016
Q4
$4K Buy
+17
New +$4K ﹤0.01% 3130
2016
Q2
Sell
-16
Closed -$1K 4490
2016
Q1
$1K Sell
16
-239
-94% -$14.9K ﹤0.01% 3656
2015
Q4
$12K Buy
255
+250
+5,000% +$11.8K ﹤0.01% 1876
2015
Q3
$0 Sell
5
-26
-84% ﹤0.01% 4105
2015
Q2
$3K Buy
+31
New +$3K ﹤0.01% 3527